๐ข Recruiting
Phase 2
๐ Investigational Drug / Biologic
NCT06344052
To Assess the Safety and Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma
๐ Research Site โ Phoenix, Arizona
View Study & Checklist โ